Literature DB >> 18156203

Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy.

Paul Knaapen1, Tjeerd Germans, Paolo G Camici, Ornella E Rimoldi, Folkert J ten Cate, Jurrien M ten Berg, Pieter A Dijkmans, Ronald Boellaard, Willem G van Dockum, Marco J W Götte, Jos W R Twisk, Albert C van Rossum, Adriaan A Lammertsma, Frans C Visser.   

Abstract

Impaired hyperemic myocardial blood flow (MBF) in hypertrophic cardiomyopathy (HCM), despite normal epicardial coronary arteries, results in microvascular dysfunction. The aim of the present study was to determine the relative contribution of extravascular compressive forces to microvascular dysfunction in HCM. Eighteen patients with symptomatic HCM and normal coronary arteries and 10 age-matched healthy volunteers were studied with PET to quantify resting and hyperemic MBF at a subendocardial and subepicardial level. In HCM patients, MRI was performed to determine left ventricular (LV) mass index (LVMI) and volumes, echocardiography to assess diastolic perfusion time, heart catheterization to measure LV outflow tract gradient (LVOTG) and LV pressures, and serum NH(2)-terminal pro-brain natriuretic peptide (NT-proBNP) as a biochemical marker of LV wall stress. Hyperemic MBF was blunted in HCM vs. controls (2.26 +/- 0.97 vs. 2.93 +/- 0.64 ml min(-1) g(-1), P < 0.05). In contrast to controls (1.38 +/- 0.15 to 1.25 +/- 0.19, P = not significant), the endocardial-to-epicardial MBF ratio decreased significantly in HCM during hyperemia (1.20 +/- 0.11 to 0.88 +/- 0.18, P < 0.01). This pattern was similar for hypertrophied septum and lateral wall. Hyperemic MBF was inversely correlated with LVOTG, NT-proBNP, left atrial volume index, and LVMI (all P < 0.01). Multivariate regression analysis, however, revealed that only LVMI and NT-proBNP were independently related to hyperemic MBF, with greater impact at the subendocardial myocardial layer. Hyperemic MBF is more severely impaired at the subendocardial level in HCM patients. The level of impairment is related to markers of increased hemodynamic LV loading conditions and LV mass. These observations suggest that, in addition to reduced capillary density caused by hypertrophy, extravascular compressive forces contribute to microvascular dysfunction in HCM patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18156203     DOI: 10.1152/ajpheart.00233.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  37 in total

1.  Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy.

Authors:  Tetsuo Konno; Dan Chen; Libin Wang; Hiroko Wakimoto; Polakit Teekakirikul; Matthew Nayor; Masataka Kawana; Seda Eminaga; Joshua M Gorham; Kumar Pandya; Oliver Smithies; Francisco J Naya; Eric N Olson; J G Seidman; Christine E Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-05       Impact factor: 11.205

2.  Endocardial and epicardial myocardial perfusion determined by semi-quantitative and quantitative myocardial perfusion magnetic resonance.

Authors:  Abdulghani Larghat; John Biglands; Neil Maredia; John P Greenwood; Stephen G Ball; Michael Jerosch-Herold; Aleksandra Radjenovic; Sven Plein
Journal:  Int J Cardiovasc Imaging       Date:  2011-11-29       Impact factor: 2.357

3.  Evaluation of hypertrophic cardiomyopathy: new horizons for CMR?

Authors:  E E van der Wall; H M Siebelink; J J Bax
Journal:  Neth Heart J       Date:  2010-03       Impact factor: 2.380

Review 4.  The clinical utility of assessing myocardial blood flow using positron emission tomography.

Authors:  Maria Cecilia Ziadi; Rob S B Beanlands
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

5.  New frontiers for cardiac PET: looking beyond mean transmural myocardial quantification.

Authors:  Doumit Daou
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-06       Impact factor: 9.236

Review 6.  Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM).

Authors:  Roberto Sciagrà; Alessandro Passeri; Jan Bucerius; Hein J Verberne; Riemer H J A Slart; Oliver Lindner; Alessia Gimelli; Fabien Hyafil; Denis Agostini; Christopher Übleis; Marcus Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-05       Impact factor: 9.236

7.  Functional effects of a tropomyosin mutation linked to FHC contribute to maladaptation during acidosis.

Authors:  Katherine A Sheehan; Grace M Arteaga; Aaron C Hinken; Fernando A Dias; Cibele Ribeiro; David F Wieczorek; R John Solaro; Beata M Wolska
Journal:  J Mol Cell Cardiol       Date:  2010-11-01       Impact factor: 5.000

8.  Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice.

Authors:  Khalid Matrougui; Zakaria Abd Elmageed; Abd Elmageed Zakaria; Modar Kassan; Sookyoung Choi; Devika Nair; Romer A Gonzalez-Villalobos; Aziz A Chentoufi; Philip Kadowitz; Souad Belmadani; Megan Partyka
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

9.  Impact of alcohol septal ablation on left anterior descending coronary artery blood flow in hypertrophic obstructive cardiomyopathy.

Authors:  Willem G van Dockum; Paul Knaapen; Mark B M Hofman; Joost P A Kuijer; Folkert J ten Cate; Jurrien M ten Berg; Aernout M Beek; Jos W R Twisk; Albert C van Rossum
Journal:  Int J Cardiovasc Imaging       Date:  2009-02-22       Impact factor: 2.357

Review 10.  Coronary microvascular resistance: methods for its quantification in humans.

Authors:  Paul Knaapen; Paolo G Camici; Koen M Marques; Robin Nijveldt; Jeroen J Bax; Nico Westerhof; Marco J W Götte; Michael Jerosch-Herold; Heinrich R Schelbert; Adriaan A Lammertsma; Albert C van Rossum
Journal:  Basic Res Cardiol       Date:  2009-05-26       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.